TipRanks
Advertisement
Advertisement

CH:P91 Stock Latest News

Sephience: Strong Commercial Momentum and Durable Uptake Support Unchanged Buy Rating and $96 Price Target
RatingsSephience: Strong Commercial Momentum and Durable Uptake Support Unchanged Buy Rating and $96 Price Target
9h ago
PTCT
PTC Therapeutics price target lowered to $75 from $85 at RBC Capital
PremiumThe Fly
PTC Therapeutics price target lowered to $75 from $85 at RBC Capital
1d ago
PTCT
PTC Therapeutics Acquires Fabry Gene Therapy Candidate ST-920
PremiumCompany Announcements
PTC Therapeutics Acquires Fabry Gene Therapy Candidate ST-920
18d ago
8K
PTCT
PTC Therapeutics upgraded to Outperform from Market Perform at Leerink
PremiumThe Fly
PTC Therapeutics upgraded to Outperform from Market Perform at Leerink
25d ago
PTCT
PTC Therapeutics Acquires ST-920 Fabry Gene Therapy Rights
PremiumCompany Announcements
PTC Therapeutics Acquires ST-920 Fabry Gene Therapy Rights
1M ago
8K
PTCT
PTC Therapeutics announces new sephience data
PremiumThe FlyPTC Therapeutics announces new sephience data
2M ago
PTCT
PTC Therapeutics to acquire ST-920 from Sangamo Therapeutics
Premium
The Fly
PTC Therapeutics to acquire ST-920 from Sangamo Therapeutics
2M ago
PTCT
PTC Therapeutics price target raised to $109 from $106 at Wells Fargo
Premium
The Fly
PTC Therapeutics price target raised to $109 from $106 at Wells Fargo
2M ago
PTCT
PTC Therapeutics price target raised to $122 from $120 at Barclays
PremiumThe Fly
PTC Therapeutics price target raised to $122 from $120 at Barclays
2M ago
PTCT
PTC Therapeutics to Acquire ST-920 Fabry Gene Therapy
PremiumCompany Announcements
PTC Therapeutics to Acquire ST-920 Fabry Gene Therapy
2M ago
8K
PTCT
PTC Therapeutics price target raised to $96 from $95 at BofA
PremiumThe Fly
PTC Therapeutics price target raised to $96 from $95 at BofA
2M ago
PTCT
PTC Therapeutics price target raised to $104 from $93 at Morgan Stanley
PremiumThe Fly
PTC Therapeutics price target raised to $104 from $93 at Morgan Stanley
2M ago
PTCT
PTC Therapeutics price target raised to $106 from $93 at Wells Fargo
PremiumThe FlyPTC Therapeutics price target raised to $106 from $93 at Wells Fargo
2M ago
PTCT
PTC Therapeutics Raises Outlook on Strong Q2 Results
Premium
Company Announcements
PTC Therapeutics Raises Outlook on Strong Q2 Results
2M ago
8K
PTCT
PTC Therapeutics reports Q2 EPS 92c, consensus 34c
Premium
The Fly
PTC Therapeutics reports Q2 EPS 92c, consensus 34c
2M ago
PTCT
PTC Therapeutics raises 2026 revenue view to $1.18B-$1.28B from $1.08B-$1.18B
PremiumThe Fly
PTC Therapeutics raises 2026 revenue view to $1.18B-$1.28B from $1.08B-$1.18B
2M ago
PTCT
PTC Therapeutics (PTCT) Q2 Earnings Cheat Sheet
PremiumPre-Earnings
PTC Therapeutics (PTCT) Q2 Earnings Cheat Sheet
2M ago
PTCT
PTC Therapeutics price target lowered to $93 from $95 at Wells Fargo
PremiumThe Fly
PTC Therapeutics price target lowered to $93 from $95 at Wells Fargo
3M ago
PTCT
PTC Therapeutics price target raised to $130 from $124 at Cantor Fitzgerald
PremiumThe Fly
PTC Therapeutics price target raised to $130 from $124 at Cantor Fitzgerald
3M ago
PTCT
PTC Therapeutics price target raised to $95 from $93 at BofA
PremiumThe FlyPTC Therapeutics price target raised to $95 from $93 at BofA
3M ago
PTCT
PTC Therapeutics price target raised to $91 from $89 at JPMorgan
Premium
The Fly
PTC Therapeutics price target raised to $91 from $89 at JPMorgan
3M ago
PTCT
PTC Therapeutics price target raised to $85 from $82 at RBC Capital
Premium
The Fly
PTC Therapeutics price target raised to $85 from $82 at RBC Capital
3M ago
PTCT

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >